Although every cell in the body carries the genes necessary to function as an antibody-producing B cell, only a small proportion of stem cells mature into those important immune-system cells. James Hagman, PhD, Professor of Immunology at National Jewish Health and his colleagues have identified two "molecular motors" that work in opposing directions to control the development of B cells. They published their findings June 19 in the online version of The Proceedings of the National Academy of Sciences USA.
"We found that these two 'chromatin remodeling complexes' work in a sort of pushmi-pullyu manner to induce or retard epigenetic changes that allow for the development of a B cell," said Hagman. The pushmi-pullyu was a fictional animal in the Dr. Doolittle stories that had a head at opposite ends of its body, each pulling in a different direction. "The complexes help control both the unspooling of DNA to make genes accessible and the demethylation of DNA that removes silencing markers."
Although DNA in every cell contains the genes necessary to become B cells, two factors help keep them silent. One is the fact that the two meters of DNA inside a tiny cell nucleus is wrapped around millions of tiny spools, linked together like a string of pearls, which help keep the hereditary molecule from becoming irretrievably tangled. When wrapped tightly around these spools, individual genes are inaccessible to the molecules that bind and activate them. Second, many of the genes have small methyl groups, a carbon and three hydrogen atoms (CH3), on their DNA in specific places, which also prevent them from being activated. These factors are considered epigenetic states, modifications to existing DNA that control their activation or silencing.
Dr. Hagman and his colleagues previously identified a protein, known as Early B-cell Factor or EBF, which they dubbed a 'pioneer factor.' By altering the epigenetic state of several genes, it is estimate
'/>"/>
| Contact: William Allstetter allstetterw@njc.org 303-398-1002 National Jewish Medical and Research Center Source:Eurekalert |
Related biology news :
1. HIV-1 protease inhibitor induced oxidative stress in pancreatic B-cells: thymoquinone protection
2. Gender, coupled with diabetes, affects vascular disease development
3. New target for anti-flu drug development
4. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
5. KAUST and American University in Cairo to collaborate on research and academic development
6. Old developmental pathways spawn revolutionary evolutionary changes
7. NIST announces 56 new awards for innovative technology research and development
8. Progress Against Malaria: Developments on the Horizon
9. Flu vaccine in painless skin patches under development at Emory, Georgia Tech with NIH grants
10. Biopharmaceutical infrastructure key to lower drug development costs
11. Study identifies pathway required for normal reproductive development
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |